Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
Yusuke Inoue(Hamamatsu University School of Medicine), Takafumi Suda(Hamamatsu University School of Medicine)
Cited by 14
Related Papers
Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer
|Oncotarget|2017|173
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancer
|Cancer Immunology Immunotherapy|2021|44